Buscar alternativas:
"otro apel" » "otro el" (Expander búsqueda), "otro del" (Expander búsqueda), "otro al" (Expander búsqueda)
"esto open" » "tests open" (Expander búsqueda), "esto en" (Expander búsqueda), "nest open" (Expander búsqueda)
"oto open" » "two open" (Expander búsqueda)
"do open" » "two open" (Expander búsqueda)
"esmo open" » "eso open" (Expander búsqueda), "ecmo open" (Expander búsqueda)
Mostrando 1 - 20 Resultados de 1,154 Para Buscar '(((((("oto open") OR ("otro apel"))) OR ((("esmo open") OR ("esto open"))))) OR ("do open"))', tiempo de consulta: 1.64s Limitar resultados
Presenting OTO Open
AIOM chooses ESMO Open—Cancer Horizons as its official journal: a warm welcome from ESMO Open

ESMO Open—Cancer Horizons and the future of oncology
CSCO joins ESMO Open—Cancer Horizons

ESMO Open: news in breast cancer 2019
ESMO Open welcomes the association with the Japanese Society of Medical Oncology (JSMO)

ESMO Open special series on new emerging targets in cancer immunotherapy
Announcing the ESMO Open special issue on upcoming molecular targets for cancer treatment

One year of ESMO Open: Cancer Horizons—where are we going from here?
Introducing a new ESMO Open article series: how I treat side effects of immunotherapy

Managing toxicities with asparaginase-based therapies in adult ALL: summary of an ESMO Open–Cancer Horizons roundtable discussion
First-line PARP inhibitors in ovarian cancer: summary of an ESMO Open - Cancer Horizons round-table discussion

CDK4/6 inhibition in low burden and extensive metastatic breast cancer: summary of an ESMO Open—Cancer Horizons pro and con discussion
Desafios do Open Design

New emerging targets in cancer immunotherapy beyond CTLA-4, PD-1 and PD-L1: Introducing an “ESMO Open – Cancer Horizons” Series
Erratum to ‘FOLFIRINOX or FOLFOXIRI in locally advanced duodenal adenocarcinoma: are we missing out?’: [ESMO Open Volume 5, Issue 5, 2020, e000633]

Adoção do Open Peer Review
How do Openers Contribute to Student Learning?

Criptografia digital: implementação do OpenPGP
Erratum to ‘Adjuvant endocrine therapy in HER2-positive breast cancer patients: systematic review and meta-analysis’: [ESMO Open Volume 6, Issue 2, April 2021, 100088]

Herramientas de búsqueda: RSS — Enviar por Correo electrónico esta Búsqueda — Guardar Búsqueda